Kerry Hylands
About Kerry Hylands
Kerry Hylands is a Senior Clinical Project Manager at Aimmune Therapeutics in London, with extensive experience in clinical trials and project management. She has held various roles in organizations such as University College London, King's College Hospital, and Norgine, contributing to multiple phases of clinical research.
Current Role at Aimmune Therapeutics
Kerry Hylands currently serves as a Senior Clinical Project Manager at Aimmune Therapeutics, a position she has held since 2020. In this role, she oversees clinical projects and contributes to the strategic direction of clinical trials. Kerry has chaired the Study Execution Team meeting for a complex phase III pivotal study, demonstrating her leadership in managing critical clinical research initiatives. Additionally, she has acted as CRO Business Process Manager, playing a key role in integration committees following Aimmune's acquisition.
Previous Experience in Clinical Trials
Kerry Hylands has extensive experience in clinical trials, having worked in various capacities across multiple organizations. She began her career as a Clinical Data Monitor at Covance from 2007 to 2009. She then served as a Clinical Trials Coordinator and Clinical Trials Officer at King's College Hospital from 2010 to 2012. Following this, she worked as a Clinical Project Manager at Norgine from 2015 to 2018. Prior to her current role, she was a Clinical Project Manager at Aimmune Therapeutics from 2018 to 2020.
Educational Background
Kerry Hylands has a solid educational foundation in the life sciences. She studied at the University of Leeds, where she earned a Bachelor of Science with Honors in Biological Sciences from 2004 to 2007. She furthered her education at the Institute of Clinical Research, achieving a Diploma and Certificate in 2016. Additionally, she attended Watford Grammar School for Girls, where she completed her secondary education.
Key Contributions and Responsibilities
In her roles, Kerry Hylands has managed significant clinical studies, including a Phase IV outsourced arthritis study while line managing a Clinical Project Manager. She has been involved in the development of specifications and user acceptance testing for essential trial tools such as IXRS, CTMS, and eCRF. Her contributions have been critical in ensuring the successful execution of clinical trials and the integration of processes within the organizations she has worked for.